May 30, 2018 | Harriet Kozak, Intellus, Rachel Howard, USA, emerging markets
Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
The theme of the conference was ‘7 billion voices’, exploring how patient experiences, programs and health literacy can be improved through insights delivered by market researchers in the pharmaceutical industry.
As part of the keynote speeches, we were honored to hear the perspective of patient advocates and leaders in rare disease. Hearing directly from patients who had lived through unimaginably challenging experiences provided a humbling reminder and refocusing of our common goal as an industry – to ultimately improve patients’ lives.
Find out more:Â https://www.researchpartnership.com/news/2018/05/intellus-round-up-2018/
This content was provided by Inizio
Latest Content from Inizio
As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn’t…
Brighton-based independent healthcare specialist continues to showcase its digital expertise with shortlist nomination
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with…
Pegasus, the UK’s leading independent health communications consultancy, picked up the much coveted ‘Consultancy of the Year’ award at last week’s Communiqué Awards 2014, fighting off stiff competition from the…
If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to…
Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding.
